News
In this video interview, Ron Lanton, partner, Lanton Law, discusses how a potential increase in drug costs could affect the ...
MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback